Effect of injectable contraceptive use on response to antiretroviral therapy among women in Rakai, Uganda

Contraception

Volumn 86, Issue 6, 2012, Pages 725-730

  Polis, Chelsea B ^a   Nakigozi, Gertrude ^b   Ssempijja, Victor ^b   Makumbi, Fredrick E ^c   Boaz, Iga ^b   Reynolds, Steven J ^d,e   Ndyanabo, Anthony ^b   Lutalo, Tom ^b   Wawer, Maria J ^a   Gray, Ronald H ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b RAKAI HEALTH SCIENCES PROGRAM   (Uganda)

^c MAKERERE UNIVERSITY   (Uganda)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antiretroviral therapy; Family planning; HIV; Hormonal contraception; Injectable contraception; Uganda

Indexed keywords

ANTIRETROVIRUS AGENT; EFAVIRENZ; INJECTABLE CONTRACEPTIVE AGENT; LAMIVUDINE; NEVIRAPINE; STAVUDINE; ZIDOVUDINE;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG TREATMENT FAILURE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PREVALENCE; RISK ASSESSMENT; TREATMENT RESPONSE; UGANDA; VIRUS INHIBITION; VIRUS LOAD; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; ANTI-RETROVIRAL AGENTS; COMMUNITY HEALTH SERVICES; CONTRACEPTIVE AGENTS, FEMALE; DRUG IMPLANTS; DRUG INTERACTIONS; DRUG MONITORING; DRUG RESISTANCE, VIRAL; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HIV-1; HUMANS; LOST TO FOLLOW-UP; MEDICATION ADHERENCE; MEDROXYPROGESTERONE ACETATE; UGANDA; VIRAL LOAD; YOUNG ADULT;

EID: 84869089166     PISSN: 00107824     EISSN: 18790518     Source Type: Journal    
DOI: 10.1016/j.contraception.2012.05.001     Document Type: Article

References (27)

1. C. Marston, and J. Cleland Relationships between contraception and abortion: a review of the evidence Int Fam Plan Perspect 29 2003 6 13 (Pubitemid 36650094)
2. H.W. Reynolds, M.J. Steiner, and W. Cates Jr. Contraception's proved potential to fight HIV Sex Transm Infect 81 2005 184 185 (Pubitemid 40523841)
3. K. Nanda Hormonal contraceptive use in women treated with antiretroviral drugs WHO Meeting on Research Priorities on HC and IUDs and HIV 2007
4. J. Cocohoba Hormonal contraception for HIV positive women BETA 22 2010 36 40
5. S.Y. El-Ibiary, and J.M. Cocohoba Effects of HIV antiretrovirals on the pharmacokinetics of hormonal contraceptives Eur J Contracept Reprod Health Care 13 2008 123 132 (Pubitemid 352000659)
6. World Health Organization Medical eligibility criteria for contraceptive use 4th ed 2009 WHO Geneva
7. World Health Organization Hormonal contraception and HIV: technical statement 2012 Geneva, Switzerland
8. United Nations, Department of Economic, Social Affairs, and Population Division World Contraceptive Use 2011 2011 United Nations New York City
9. D.H. Watts, J.G. Park, and S.E. Cohn Safety and tolerability of depot medroxyprogesterone acetate among HIV-infected women on antiretroviral therapy: ACTG A5093 Contraception 77 2008 84 90
10. K. Nanda, E. Amaral, and M. Hays Pharmacokinetic interactions between depot medroxyprogesterone acetate and combination antiretroviral therapy Fertil Steril 90 2008 965 971
11. F.T. Aweeka, S.L. Rosenkranz, and Y. Segal The impact of sex and contraceptive therapy on the plasma and intracellular pharmacokinetics of zidovudine AIDS 20 2006 1833 1841 (Pubitemid 44358901)
12. S.E. Cohn, J.G. Park, and D.H. Watts Park J.G., Watts DH, et al. Depo-medroxyprogesterone in Women on Antiretroviral Therapy: effective Contraception and Lack of Clinically Significant Interactions Clin Pharmacol Ther 81 2007 222 227 (Pubitemid 46174819)
13. J.H. Chu, S.J. Gange, and K. Anastos Hormonal contraceptive use and the effectiveness of highly active antiretroviral therapy Am J Epidemiol 161 2005 881 890 (Pubitemid 40577843)
14. K.S. Ingersoll, and J. Cohen The impact of medication regimen factors on adherence to chronic treatment: a review of literature J Behav Med 31 2008 213 224
15. A. Boulle, C.G. Van, and K. Cohen Outcomes of nevirapine- and efavirenz-based antiretroviral therapy when coadministered with rifampicin-based antitubercular therapy JAMA 300 2008 530 539
16. D. Westreich, S.R. Cole, and S. Nagar Pregnancy and virologic response to antiretroviral therapy in South Africa PLoS One 6 2011 e22778
17. J.C. Chalker, T. Andualem, and L.N. Gitau Measuring adherence to antiretroviral treatment in resource-poor settings: the feasibility of collecting routine data for key indicators BMC Health Serv Res 10 2010 43
18. D. Ross-Degnan, M. Pierre-Jacques, and F. Zhang Measuring adherence to antiretroviral treatment in resource-poor settings: the clinical validity of key indicators BMC Health Serv Res 10 2010 42
19. G. Zou A modified Poisson regression approach to prospective studies with binary data Am J Epidemiol 159 2004 702 706 (Pubitemid 38405384)
20. S.J. Reynolds, G. Nakigozi, and K. Newell Failure of immunologic criteria to appropriately identify antiretroviral treatment failure in Uganda AIDS 23 2009 697 700
21. S.G. Deeks, J.D. Barbour, and R.M. Grant Duration and predictors of CD4 T-cell gains in patients who continue combination therapy despite detectable plasma viremia AIDS 16 2002 201 207 (Pubitemid 34118567)
22. World Health Organization Antiretroviral therapy for HIV infection in adults and adolescents: Recommendations for a public health approach (2010 revision) 2010 World Health Organization Press Geneva, Swizerland
23. C.B. Polis, R.H. Gray, and T. Lutalo Trends and correlates of hormonal contraceptive use among HIV-infected women in Rakai, Uganda, 1994-2006 Contraception 83 2011 549 555
24. C. Unge, B. Sodergard, and G. Marrone Long-term adherence to antiretroviral treatment and program drop-out in a high-risk urban setting in sub-Saharan Africa: a prospective cohort study PLoS One 5 2010 e13613
25. G. Nakigozi, F. Makumbi, and S. Reynolds Non-enrollment for free community HIV care: findings from a population-based study in Rakai, Uganda AIDS Care 2011 1 7
26. P. Braitstein, A. Boulle, and D. Nash Gender and the use of antiretroviral treatment in resource-constrained settings: findings from a multicenter collaboration J Womens Health (Larchmt) 17 2008 47 55 (Pubitemid 351197536)
27. B.N. Mayanja, L.A. Shafer, and L. Van der Paal Effect of pregnancy on immunological and virological outcomes of women on ART: a prospective cohort study in rural Uganda, 2004-2009 Trop Med Int Health 2011 Dec 30 http://dx.doi.org/10.1111/j.1365-3156.2011.02921.x [Epub ahead of print]